Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:03:35.759Z.
Calculation as of: 2026-10-06T16:03:35.759Z.
Quote observation: 2026-10-06T16:00:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2eba736d2827de544c9f141b3fafa3dea8ffa5f0a614b8c2b2ac1915a5af89f6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Century Therapeutics, Inc.
Market Cap
$248.98M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$247.93M
Free Cash Flow Yield
N/A
TTM Avg
12.33%
3Y Avg
12.33%
5Y Avg
12.33%
Market Cap
$252.05M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$252.22M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.34M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.66M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.81M
Free Cash Flow Yield
N/A
TTM Avg
1.67%
3Y Avg
1.64%
5Y Avg
2.28%
Market Cap
$240.82M
Free Cash Flow Yield
16.68%
TTM Avg
15.02%
3Y Avg
15.02%
5Y Avg
15.02%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $248.98M | N/A | N/A | N/A | N/A |
| Q32 Bio Inc. (QTTB)vs › | $247.93M | N/A | 12.33% | 12.33% | 12.33% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $252.05M | N/A | N/A | N/A | N/A |
| Quantum-Si incorporated (QSI)vs › | $252.22M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $244.64M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $243.34M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.66M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.81M | N/A | 1.67% | 1.64% | 2.28% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.82M | 16.68% | 15.02% | 15.02% | 15.02% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.66M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
